Skip to content

Investigation of hyperammonemia due to valproic acid in Okinawa

Investigation of hyperammonemia due to valproic acid in Okinawa - Investigation of hyperammonemia due to valproic acid in Okinawa

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000015116
Enrollment
1000
Registered
2014-09-12
Start date
2013-02-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychiatric disorder

Interventions

None listed

Sponsors

University of the Ryukyus, School of medicine, Department of neuropsychiatry
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The person who takes valproic acid The person with the ability for agreement

Exclusion criteria

Exclusion criteria: The pregnancy or the person who has the possibilities The person that ability for agreement has a problem

Design outcomes

Primary

MeasureTime frame
Blood valproic acid level, blood ammonia level, blood carnitine level

Countries

Japan

Contacts

Public ContactAkifumi Nakamura

University of the Ryukyus, School of medicine Department of neuropsychiatry

anakamura-oki@umin.ac.jp098-895-1157

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026